{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T19:48:31Z","timestamp":1757706511110},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1097\/mca.0000000000000730","type":"journal-article","created":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T20:25:14Z","timestamp":1553027114000},"page":"255-262","source":"Crossref","is-referenced-by-count":7,"title":["Comparative effectiveness of different contemporary drug-eluting stents in routine clinical practice"],"prefix":"10.1097","volume":"30","author":[{"given":"Osung","family":"Kwon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Se Hun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Bok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Min","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheol Hyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Do-Yoon","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pil Hyung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo-Jin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Whan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Hak","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheol Whan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong-Wook","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duk-Woo","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Jung","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-3-20210204","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(07)61444-5","article-title":"Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis","volume":"370","author":"Stettler","year":"2007","journal-title":"Lancet"},{"key":"R2-3-20210204","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJMra1210816","article-title":"Drug-eluting coronary-artery stents","volume":"368","author":"Stefanini","year":"2013","journal-title":"N Engl J Med"},{"key":"R3-3-20210204","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1161\/CIRCULATIONAHA.112.097014","article-title":"Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117\u2009762 patient-years of follow-up from randomized trials","volume":"125","author":"Bangalore","year":"2012","journal-title":"Circulation"},{"key":"R4-3-20210204","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jacc.2013.09.061","article-title":"Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis","volume":"63","author":"Palmerini","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R5-3-20210204","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1016\/j.jacc.2015.04.017","article-title":"Long-term safety of drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis","volume":"65","author":"Palmerini","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"R6-3-20210204","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jacc.2015.11.051","article-title":"Safety and efficacy of everolimus- versus sirolimus-eluting stents: 5-year results from SORT OUT IV","volume":"67","author":"Jensen","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R7-3-20210204","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/eurheartj\/ehr479","article-title":"Lower risk of stent thrombosis and restenosis with unrestricted use of \u2018new-generation\u2019 drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR)","volume":"33","author":"Sarno","year":"2012","journal-title":"Eur Heart J"},{"key":"R8-3-20210204","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1056\/NEJMoa1607991","article-title":"Drug-eluting or bare-metal stents for coronary artery disease","volume":"375","author":"Bonaa","year":"2016","journal-title":"N Engl J Med"},{"key":"R9-3-20210204","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1056\/NEJMoa1004130","article-title":"Comparison of zotarolimus-eluting and everolimus-eluting coronary stents","volume":"363","author":"Serruys","year":"2010","journal-title":"N Engl J Med"},{"key":"R10-3-20210204","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.jacc.2011.02.016","article-title":"A prospective, randomized evaluation of a novel everolimus-eluting coronary stent: the PLATINUM (a Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System [PROMUS Element] for the Treatment of Up to Two de Novo Coronary Artery Lesions) trial","volume":"57","author":"Stone","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R11-3-20210204","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(12)61852-2","article-title":"Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial","volume":"381","author":"Smits","year":"2013","journal-title":"Lancet"},{"key":"R12-3-20210204","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(13)62037-1","article-title":"Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial","volume":"383","author":"Von Birgelen","year":"2014","journal-title":"Lancet"},{"key":"R13-3-20210204","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1016\/j.jacc.2014.04.013","article-title":"A randomized comparison of platinum chromium-based everolimus-eluting stents versus cobalt chromium-based zotarolimus-Eluting stents in all-comers receiving percutaneous coronary intervention: HOST-ASSURE (harmonizing optimal strategy for treatment of coronary artery stenosis-safety & effectiveness of drug-eluting stents & anti-platelet regimen), a randomized, controlled, noninferiority trial","volume":"63","author":"Park","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R14-3-20210204","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0140-6736(14)61794-3","article-title":"Zotarolimus-eluting durable-polymer-coated stent versus a biolimus-eluting biodegradable-polymer-coated stent in unselected patients undergoing percutaneous coronary intervention (SORT OUT VI): a randomised non-inferiority trial","volume":"385","author":"Raungaard","year":"2015","journal-title":"Lancet"},{"key":"R15-3-20210204","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/CIRCINTERVENTIONS.111.966549","article-title":"Outcomes after unrestricted use of everolimus-eluting and sirolimus-eluting stents in routine clinical practice: a multicenter, prospective cohort study","volume":"5","author":"Park","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"R16-3-20210204","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.jacc.2013.08.720","article-title":"Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI)","volume":"62","author":"Moussa","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R17-3-20210204","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1161\/CIRCULATIONAHA.107.688416","article-title":"Thrombosis in coronary drug-eluting stents: report from the meeting of the Circulatory System Medical Devices Advisory Panel of the Food and Drug Administration Center for Devices and Radiologic Health, 7\u20138 December 2006","volume":"115","author":"Laskey","year":"2007","journal-title":"Circulation"},{"key":"R18-3-20210204","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","article-title":"The central role of the propensity score in observational studies for causal effects","volume":"70","author":"Rosenbaum","year":"1983","journal-title":"Biometrika"},{"key":"R19-3-20210204","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1002\/sim.5753","article-title":"A tutorial on propensity score estimation for multiple treatments using generalized boosted models","volume":"32","author":"McCaffrey","year":"2013","journal-title":"Stat Med"},{"key":"R20-3-20210204","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jacc.2011.12.057","article-title":"Future directions for cardiovascular disease comparative effectiveness research: report of a workshop sponsored by the National Heart, Lung, and Blood Institute","volume":"60","author":"Hlatky","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R21-3-20210204","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jacc.2010.03.086","article-title":"Comparison of zotarolimus-eluting stents with sirolimus- and paclitaxel-eluting stents for coronary revascularization: the ZEST (comparison of the efficacy and safety of zotarolimus-eluting stent with sirolimus-eluting and paclitaxel-eluting stent for coronary lesions) randomized trial","volume":"56","author":"Park","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"R22-3-20210204","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1161\/CIRCULATIONAHA.109.876763","article-title":"C-reactive protein and the risk of stent thrombosis and cardiovascular events after drug-eluting stent implantation","volume":"120","author":"Park","year":"2009","journal-title":"Circulation"},{"key":"R23-3-20210204","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1056\/NEJMoa1001266","article-title":"Duration of dual antiplatelet therapy after implantation of drug-eluting stents","volume":"362","author":"Park","year":"2010","journal-title":"N Engl J Med"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000000730","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:43:40Z","timestamp":1620960220000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00019501-201906000-00003"}},"subtitle":["a multigroup propensity score analysis using data from the stent-specific, multicenter, prospective registries"],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000000730","relation":{},"ISSN":["0954-6928"],"issn-type":[{"value":"0954-6928","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]}}}